Literature DB >> 30031564

Biological Variability of Estimated GFR and Albuminuria in CKD.

Sushrut S Waikar1, Casey M Rebholz2, Zihe Zheng2, Shelley Hurwitz3, Chi-Yuan Hsu4, Harold I Feldman5, Dawei Xie5, Kathleen D Liu4, Theodore E Mifflin5, John H Eckfeldt6, Paul L Kimmel7, Ramachandran S Vasan8, Joseph V Bonventre3, Lesley A Inker9, Josef Coresh2.   

Abstract

RATIONALE &
OBJECTIVE: Determining whether a change in estimated glomerular filtration rate (eGFR) or albuminuria is clinically significant requires knowledge of short-term within-person variability of the measurements, which few studies have addressed in the setting of chronic kidney disease. STUDY
DESIGN: Cross-sectional study with multiple collections over less than 4 weeks. SETTING & PARTICIPANTS: Clinically stable outpatients with chronic kidney disease (N=50; mean age, 56.8 years; median eGFR, 40mL/min/1.73m2; median urinary albumin-creatinine ratio (UACR), 173mg/g). EXPOSURE: Repeat measurements from serially collected samples across 3 study visits. OUTCOMES: Measurements of urine albumin concentration (UAC), UACR, and plasma creatinine, cystatin C, β2-microglobulin (B2M), and beta trace protein (BTP). ANALYTICAL APPROACH: We calculated within-person coefficients of variation (CVw) values and corresponding reference change positive and negative (RCVpos and RCVneg) values using log-transformed measurements.
RESULTS: Median CVw (RCVpos; RCVneg) values of filtration markers were 5.4% (+16%; -14%) for serum creatinine, 4.1% (+12%; -11%) for cystatin C, 7.4% (+23%; -18%) for BTP, and 5.6% (+17%; -14%) for B2M. Results for albuminuria were 33.2% (+145%; -59%) for first-morning UAC, 50.6% (+276%; -73%) for random spot UAC, 32.5% (+141%; -58%) for first-morning UACR, and 29.7% (124%; -55%) for random spot UACR. CVw values for filtration markers were comparable across the range of baseline eGFRs. CVw values for UAC and UACR were comparable across the range of baseline albuminuria values. LIMITATIONS: Small sample size limits the ability to detect differences in variability across markers. Participants were recruited and followed up in a clinical and not research setting, so some preanalytical factors could not be controlled.
CONCLUSIONS: eGFR markers appear to have relatively low short-term within-person variability, whereas variability in albuminuria appears to be high, making it difficult to distinguish random variability from meaningful biologic changes.
Copyright © 2018 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Albuminuria; beta trace protein (BTP); biological variability; biomarker; clinically meaningful differences; coefficient of variation (CV); cystatin C; estimated glomerular filtration rate (eGFR); filtration marker; intraindividual variation; kidney function; laboratory measurement; reproducibility; serum creatinine; urinary albumin-creatinine ratio (UACR); β(2)-microglobulin (B2M)

Mesh:

Substances:

Year:  2018        PMID: 30031564      PMCID: PMC6469385          DOI: 10.1053/j.ajkd.2018.04.023

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  35 in total

1.  Circadian rhythms in systemic hemodynamics and renal function in healthy subjects and patients with nephrotic syndrome.

Authors:  A J Voogel; M G Koopman; A A Hart; G A van Montfrans; L Arisz
Journal:  Kidney Int       Date:  2001-05       Impact factor: 10.612

2.  Imprecision of urinary iothalamate clearance as a gold-standard measure of GFR decreases the diagnostic accuracy of kidney function estimating equations.

Authors:  Yuen-Ting Diana Kwong; Lesley A Stevens; Elizabeth Selvin; Yaping Lucy Zhang; Tom Greene; Frederick Van Lente; Andrew S Levey; Josef Coresh
Journal:  Am J Kidney Dis       Date:  2010-07       Impact factor: 8.860

3.  Discrepancy between circadian rhythms of inulin and creatinine clearance.

Authors:  B A van Acker; G C Koomen; M G Koopman; R T Krediet; L Arisz
Journal:  J Lab Clin Med       Date:  1992-09

4.  Circadian rhythm of glomerular filtration rate in normal individuals.

Authors:  M G Koopman; G C Koomen; R T Krediet; E A de Moor; F J Hoek; L Arisz
Journal:  Clin Sci (Lond)       Date:  1989-07       Impact factor: 6.124

5.  Trends in Prevalence of Chronic Kidney Disease in the United States.

Authors:  Daniel Murphy; Charles E McCulloch; Feng Lin; Tanushree Banerjee; Jennifer L Bragg-Gresham; Mark S Eberhardt; Hal Morgenstern; Meda E Pavkov; Rajiv Saran; Neil R Powe; Chi-Yuan Hsu
Journal:  Ann Intern Med       Date:  2016-08-02       Impact factor: 25.391

6.  Estimating glomerular filtration rate from serum creatinine and cystatin C.

Authors:  Lesley A Inker; Christopher H Schmid; Hocine Tighiouart; John H Eckfeldt; Harold I Feldman; Tom Greene; John W Kusek; Jane Manzi; Frederick Van Lente; Yaping Lucy Zhang; Josef Coresh; Andrew S Levey
Journal:  N Engl J Med       Date:  2012-07-05       Impact factor: 91.245

7.  Spectrum of diurnal rhythms in glomerular permeability in patients with membranous nephropathy.

Authors:  M G Koopman; L Arisz
Journal:  Nephrol Dial Transplant       Date:  1997       Impact factor: 5.992

8.  Spot PC ratio estimates of 24-hour proteinuria are more unreliable in lupus nephritis than in other forms of chronic glomerular disease.

Authors:  Daniel J Birmingham; Ganesh Shidham; Annalisa Perna; Derek M Fine; Michael Bissell; Roger Rodby; Giuseppi Remuzzi; Michele Petri; Paul Hebert; Brad H Rovin; Lee A Hebert
Journal:  Ann Rheum Dis       Date:  2013-10-03       Impact factor: 19.103

9.  Within-person variability in kidney measures.

Authors:  Elizabeth Selvin; Stephen P Juraschek; John Eckfeldt; Andrew S Levey; Lesley A Inker; Josef Coresh
Journal:  Am J Kidney Dis       Date:  2013-01-20       Impact factor: 8.860

10.  GFR Estimation Using β-Trace Protein and β2-Microglobulin in CKD.

Authors:  Lesley A Inker; Hocine Tighiouart; Josef Coresh; Meredith C Foster; Amanda H Anderson; Gerald J Beck; Gabriel Contreras; Tom Greene; Amy B Karger; John W Kusek; James Lash; Julia Lewis; Jeffrey R Schelling; Sankar D Navaneethan; James Sondheimer; Tariq Shafi; Andrew S Levey
Journal:  Am J Kidney Dis       Date:  2015-09-09       Impact factor: 8.860

View more
  24 in total

1.  Plasma copeptin levels predict disease progression and tolvaptan efficacy in autosomal dominant polycystic kidney disease.

Authors:  Ron T Gansevoort; Maatje D A van Gastel; Arlene B Chapman; Jaime D Blais; Frank S Czerwiec; Eiji Higashihara; Jennifer Lee; John Ouyang; Ronald D Perrone; Katrin Stade; Vicente E Torres; Olivier Devuyst
Journal:  Kidney Int       Date:  2019-03-09       Impact factor: 10.612

2.  Aligning Albuminuria and Proteinuria Measurements.

Authors:  Josef Coresh
Journal:  J Am Soc Nephrol       Date:  2020-02-05       Impact factor: 10.121

Review 3.  Urinary strips for protein assays: easy to do but difficult to interpret!

Authors:  Guillaume Résimont; Laurence Piéroni; Edith Bigot-Corbel; Etienne Cavalier; Pierre Delanaye
Journal:  J Nephrol       Date:  2020-04-23       Impact factor: 3.902

4.  An Electronic CKD Phenotype: A Step Forward in Improving Kidney Care.

Authors:  Sri Lekha Tummalapalli; Carmen A Peralta
Journal:  Clin J Am Soc Nephrol       Date:  2019-08-12       Impact factor: 8.237

5.  Metabolomic Markers of Kidney Function Decline in Patients With Diabetes: Evidence From the Chronic Renal Insufficiency Cohort (CRIC) Study.

Authors:  Brian Kwan; Tobias Fuhrer; Jing Zhang; Manjula Darshi; Benjamin Van Espen; Daniel Montemayor; Ian H de Boer; Mirela Dobre; Chi-Yuan Hsu; Tanika N Kelly; Dominic S Raj; Panduranga S Rao; Santosh L Saraf; Julia Scialla; Sushrut S Waikar; Kumar Sharma; Loki Natarajan
Journal:  Am J Kidney Dis       Date:  2020-05-05       Impact factor: 8.860

6.  Multiplex Serum Biomarker Assays Improve Prediction of Renal and Mortality Outcomes in Chronic Kidney Disease.

Authors:  William P Martin; Chloe Conroy; Serika D Naicker; Sarah Cormican; Tomás P Griffin; Md Nahidul Islam; Eibhlin M McCole; Ivan McConnell; John Lamont; Peter FitzGerald; John P Ferguson; Ciarán Richardson; Susan E Logue; Matthew D Griffin
Journal:  Kidney360       Date:  2021-05-21

7.  Systematic Review and Meta-Analysis of Plasma and Urine Biomarkers for CKD Outcomes.

Authors:  Caroline Liu; Neha Debnath; Gohar Mosoyan; Kinsuk Chauhan; George Vasquez-Rios; Celine Soudant; Steve Menez; Chirag R Parikh; Steven G Coca
Journal:  J Am Soc Nephrol       Date:  2022-07-20       Impact factor: 14.978

Review 8.  Measured and estimated glomerular filtration rate: current status and future directions.

Authors:  Andrew S Levey; Josef Coresh; Hocine Tighiouart; Tom Greene; Lesley A Inker
Journal:  Nat Rev Nephrol       Date:  2019-09-16       Impact factor: 28.314

9.  The early natural history of albuminuria in young adults with youth-onset type 1 and type 2 diabetes.

Authors:  Anna R Kahkoska; Scott Isom; Jasmin Divers; Elizabeth J Mayer-Davis; Lawrence Dolan; Amy S Shah; Maryam Afkarian; David J Pettitt; Jean M Lawrence; Santica Marcovina; Sharon H Saydah; Dana Dabelea; David M Maahs; Amy K Mottl
Journal:  J Diabetes Complications       Date:  2018-10-04       Impact factor: 3.219

Review 10.  Kidney Disease, Race, and GFR Estimation.

Authors:  Andrew S Levey; Silvia M Titan; Neil R Powe; Josef Coresh; Lesley A Inker
Journal:  Clin J Am Soc Nephrol       Date:  2020-05-11       Impact factor: 8.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.